Exelixis Inc (EXEL)

Add to Watchlists
Create an Alert
21.23 -1.03  -4.63% NASDAQ Feb 19, 13:53 Delayed 2m USD
View Full Chart
EXEL Price Chart
View All Events

EXEL Events

Date Type Description
05/02/2019 17:00 EDT Misc Exelixis Inc First Quarter Earnings Conference Call in 2019
05/02/2019 Earnings Exelixis Inc First Quarter Earnings in 2019 Release
02/12/2019 17:00 EST Misc Exelixis Inc Fourth Quarter Earnings Conference Call in 2018
02/12/2019 Earnings Exelixis Inc Fourth Quarter Earnings in 2018 Release
11/01/2018 17:00 EDT Misc Exelixis Inc Third Quarter Earnings Conference Call in 2018
11/01/2018 Earnings Exelixis Inc Third Quarter Earnings Results in 2018
08/01/2018 17:00 EDT Misc Exelixis Inc Second Quarter Earnings Conference Call in 2018
08/01/2018 Earnings Exelixis Inc Second Quarter Earnings Results in 2018
05/23/2018 Misc Exelixis Inc Annual General Meeting in 2017
05/02/2018 17:00 EDT Misc Exelixis Inc First Quarter Earnings Conference Call in 2018
View All Performance Charts

EXEL Total Returns Comparison

Advertisement

EXEL One Page Reports

Edit

Profile

  • URL: http://www.exelixis.com
  • Investor Relations URL: http://www.exelixis.com/investors-media
  • HQ State/Province: California
  • Sector: Healthcare
  • Industry: Biotechnology
  • Equity Style: Mid Cap/Growth
  • Next Earnings Release: May. 02, 2019
  • Last Earnings Release: Feb. 12, 2019
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A
  • Description: Exelixis is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its lead molecule cabozantinib is indicated for the treatment of patients with metastatic medullary thyroid cancer (as Cometriq) and advanced renal cell carcinoma, or kidney cancer, and hepatocellular carcinoma, or liver cancer (as Cabometyx). Exelixis and partner Roche have also brought Cotellic to market for the treatment of melanoma. The company has partnerships with larger pharmaceutical and biotech firms to develop its pipeline, including Bristol, Sanofi, and Merck.

EXEL Comparables

Edit

EXEL Excel Add-In Codes

  • Name: =YCI("EXEL","name")
  • Description: =YCI("EXEL","description")
  • Sector: =YCI("EXEL","sector")
  • Industry: =YCI("EXEL","industry")
  • Est. Current Fiscal Year End: =YCI("EXEL","fye")

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.